IOL Chemicals and Pharmaceuticals Community

Key Takeaways Strategic market expansion and onboarding new clients could drive substantial growth in the non-ibuprofen segment. Investments in new facilities and increased export efforts may enhance revenue and profitability through operational efficiencies.